Skip to main content

Table 1 The input parameters of the log-normal survival model

From: A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society

 

Best fitting model

μ

σ

Disease-free survival

 Capecitabine

Log-normal

6.400

0.908

 Observation

Log-normal

5.437

0.753

Overall survival

 Capecitabine

Log-normal

6.074

0.627

 Observation

Log-normal

5.555

0.505

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us